Literature DB >> 7814455

Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines.

J Mestecky1, S Jackson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7814455     DOI： 10.1007/bf01540979

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  115 in total

1.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

Review 3.  The hidden tonsils of Waldeyer's ring.

Authors:  W K Dolen; B Spofford; J C Selner
Journal:  Ann Allergy       Date:  1990-10

Review 4.  Women, HIV, and mucosal immunity.

Authors:  B D Forrest
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

5.  Lymphoglandular complexes of the colon: structure and distribution.

Authors:  A D O'Leary; E C Sweeney
Journal:  Histopathology       Date:  1986-03       Impact factor: 5.087

6.  The human female reproductive tract: immunohistological localization of gamma A, gamma G, gamma M, secretory "piece," and lactoferrin.

Authors:  D R Tourville; S S Ogra; J Lippes; T B Tomasi
Journal:  Am J Obstet Gynecol       Date:  1970-12-01       Impact factor: 8.661

7.  Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.

Authors:  C J Miller; N J Alexander; S Sutjipto; S M Joye; A G Hendrickx; M Jennings; P A Marx
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

Review 8.  AIDS: an international perspective.

Authors:  P Piot; F A Plummer; F S Mhalu; J L Lamboray; J Chin; J M Mann
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

9.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

10.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.

Authors:  R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307
View more
  7 in total

Review 1.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.

Authors:  Janina Q Jiang; Xiao-Song He; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

Authors:  P A Kozlowski; S Cu-Uvin; M R Neutra; T P Flanigan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.

Authors:  G J Gorse; E Y Yang; R B Belshe; P W Berman
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

Review 5.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

6.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.

Authors:  C Farquhar; T VanCott; R Bosire; C Bermudez; D Mbori-Ngacha; B Lohman-Payne; R Nduati; P Otieno; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.